Nivolumab in Acute Myeloid Leukemia (AML) in Remission at High Risk for Relapse
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if opdivo (nivolumab) can help to
control Acute Myeloid Leukemia (AML). The safety of nivolumab will also be studied.